Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04015050
Other study ID # EBB18FI23464
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 10, 2019
Est. completion date December 3, 2021

Study information

Verified date December 2021
Source Nutricia Research
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A randomised, controlled, double-blind, parallel group, multi-country study to investigate the safety and tolerance of infant formula with prebiotics and postbiotics in healthy term infants.


Recruitment information / eligibility

Status Completed
Enrollment 279
Est. completion date December 3, 2021
Est. primary completion date December 3, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 17 Weeks
Eligibility Inclusion Criteria: - 1. Healthy, singleton, term infants (gestational age =37 weeks + 0 days and =41weeks + 6 days); 2. Infants with age at screening =14 days; 3. Birth weight within 10th to 90th percentile per gestational age and sex, according to Intergrowth Standards; 4. Head circumference at screening within ±2 SD per age and sex according to WHO Child Growth Standards; 5. a Randomised groups: Infants who are exclusively formula fed and/or whose mothers have autonomously decided to exclusively formula feed, i.e. not to breastfeed or have ended breastfeeding before screening, and who are intending to exclusively formula feed at least till their infant is 17 weeks of age; OR b Breastfed reference group: Infants who are exclusively breastfed and whose mothers are intending to exclusively breastfeed at least till their infant is 17 weeks of age; 6. Written informed consent from parent(s) and/or legal guardian(s) aged =18 years at screening. Exclusion Criteria: - 1. Randomised groups: Infants who require a special diet other than non-hydrolysed, cow's milk based infant formula (e.g. due to known or suspected to have cow's milk allergy, soy allergy and/or lactose intolerance); 2. Infants with current or previous illnesses/conditions and/or known or suspected congenital diseases or malformations which could interfere with the study or its outcome parameters, such as but not limited to: GI malformations, congenital metabolic disorders, severe congenital cardiac disorders, immunodeficiency or major surgery, as per the clinical judgement of the Investigator; 3. Infants with previous, current or intended participation in any other clinical study involving investigational or marketed products; 4. Incapability of infants' parents to comply with study protocol as per the judgement of the Investigator; 5. Infants born from mothers known to have (any) hepatitis or human immunodeficiency virus; 6. Infants born from mothers with significant medical conditions during pregnancy that might interfere with the study or its outcome parameters or known to affect intra-uterine growth (e.g. placenta previa, pre-eclampsia, eclampsia, Type 1, 2 diabetes) as per clinical judgement of the Investigator; 7. Infants born from mothers, who did participate in any clinical study involving investigational products during pregnancy, and for infants in Breastfed reference group: mothers who are currently participating or intend to participate in any clinical study involving investigational products during lactation.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
milk based infant formula
Cows milk ased infant formula

Locations

Country Name City State
Poland Poliklinika Ginekologiczno-Poloznicza Sp. z o.o. Sp. k. Bialystok

Sponsors (1)

Lead Sponsor Collaborator
Nutricia Research

Country where clinical trial is conducted

Poland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Weight gain from baseline until the age of 17 weeks (test product versus control product). Weight gain will be calculated as weight (in grams) at visit minus weight at baseline divided by the number of days. 17 weeks
See also
  Status Clinical Trial Phase
Completed NCT02646969 - Growth and Metabolic Biomarkers of Healthy Term Infants Fed Formulas With Staged Protein Concentrations Over the First Year of Life N/A
Terminated NCT01137877 - Growth and Tolerance of Healthy Term Infants to a New Infant Formula Phase 3
Completed NCT01155414 - Tolerance of Healthy Term Infants Fed Infant Formulas #4 Phase 3
Completed NCT01497314 - Growth and Safety of a Low Lactose Milk-Based Infant Formula N/A
Terminated NCT02221687 - The Combiotic-Study N/A
Completed NCT00712608 - The Evaluation of Cow's Milk Formula - Study B N/A